Corona Remedies shares rose sharply on December 15, extending gains after a blockbuster IPO debut. Strong institutional demand, consistent profitability and a focused chronic therapy portfolio have supported post-listing momentum, even as the stock trades at rich valuations, keeping investors watchful of execution and margin sustainability.Read More
Global markets face a crucial week as political negotiations in Europe, a wave of delayed US economic data and key central-bank meetings converge, shaping expectations for growth, inflation and monetary policy in the year ahead.Read More
The Reserve Bank of India will buy bonds worth 500 billion rupees ($5.52 billion) on Thursday and has included more liquid papers, including the 7.18% 2033 and former benchmark 6.33% 2035 bonds.Read More
The BOJ’s closely watched quarterly “tankan” survey, released on Monday, showed sentiment hitting a four-year high among big manufacturers, reinforcing expectations for the central bank to resume raising rates on Friday.Read More
Indian equity markets could see earnings surprises over the next one to two years as Nifty valuations hover near long-term averages, says Complete Circle Capital’s Aditya Kondawar. Banking, manufacturing and autos may lead gains, while small and midcaps could recover as trade deals progress and credit growth accelerates India’s push toward a $8 trillion economy.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
